BioPlus Co., Ltd. – Trademark Portfolio
Entity Type: 98
BioPlus Co., Ltd. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 5 are pending. Notable registered marks include BONYX, ANNIOBE, and BIOPLUS BONYX.
A-1801,1802, 18F, 14, Sagimakgol-ro, 45beon-gil, J
Seongnam-si Gyeonggi-do
Showing of trademarks Trademarks
Trademark Classifications
BioPlus Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does BioPlus Co., Ltd. have?
BioPlus Co., Ltd. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 pending.
What trademark classes does BioPlus Co., Ltd. file in?
BioPlus Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are BioPlus Co., Ltd.'s most well-known trademarks?
BioPlus Co., Ltd.'s registered trademark portfolio includes well-known marks such as BONYX, ANNIOBE, and BIOPLUS BONYX. These are among 3 currently registered trademarks in the portfolio.
What is BioPlus Co., Ltd.'s trademark registration success rate?
BioPlus Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 5 applications are pending review.